Pancreatic cancer breakthrough as scientists develop new drug that 'doubles survival rate' of silent killer
The treatment is a major breakthrough in a field where survival rates remain among the lowest of all cancers.
Only around 10 per cent of patients in Britain live for a year after diagnosis.